Item Details
London AI drug discovery startup Boltz raises $110 million Series A
Boltz, a London based artificial intelligence company focused on drug discovery, raised $110 million in Series A funding, reported on 20 November. The investment was led by Bessemer Venture Partners, with participation from Andreessen Horowitz and other investors. The company plans to expand its team and computing resources. HPC could connect healthcare technology startups with venture capital funds, pharmaceutical companies and international research partners.
Get in Touch
We’ll get back to you shortly.